4.7 Article

The rejection of endocrine disrupting and pharmaceutically active compounds by NF and RO membranes as a function of compound a water matrix properties

Journal

JOURNAL OF MEMBRANE SCIENCE
Volume 313, Issue 1-2, Pages 323-335

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.memsci.2008.01.021

Keywords

endocrine disrupting compounds; pharmaceutically active compounds; nanofiltration; reverse osmosis; fouling

Ask authors/readers for more resources

This study examined the rejection of 22 endocrine disrupting compounds (EDCs) and pharmaceutically active compounds (PhAC) from raw and 5-mu m filtered Lake Ontario water, membrane bioreactor effluent and laboratory-grade water (Milli-Q (R)) by 'loose' and 'tight' nanofiltration (NF) membranes and a reverse osmosis (RO) membrane. Rejection by the 'tight' NF membrane was most strongly correlated with compound log K-ow and water solubility with the more hydrophobic compounds showing higher rejection. The RO membrane provided efficient EDC and PhAC removal (>90%). Conversely, in general, the 'loose' NF membrane offered poor and variable compound removal. Fouling and the presence of organic matter likely contributed to higher rejections of EDCs and PhACs while higher concentrations of divalent ions appeared to result in lower EDC and PhAC rejection by the membranes. (C) 2008 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available